PL368306A1

Controlled release formulation of clarithromycin or tinidazol

Abstract

This record has no abstract on file.

Term

Term ended

Projected expiry passed 22 January 2022, 4.7 years ago.

19 members in 13 offices

This recordMember, by publication datePriority claim3 more offices are in the list below

Priority claims4

Priority claims
Document	Office	Kind	Date
0101564	International Bureau of the World Intellectual Property Organization (WIPO)	W	2001-08-29
0101564	International Bureau of the World Intellectual Property Organization (WIPO)	W	2001-08-29
01IB0101564	–	–	–
WO2001IB01564	–	–	–

Members19

Family members, oldest first
Document	Office	Kind
WO0217885A2	World Intellectual Property Organization (WIPO)	A2	2002-03-07
AU8432401A	Australia	A	2002-03-13
US2002081332A1	United States of America	A1	2002-06-27
WO0217885A3	World Intellectual Property Organization (WIPO)	A3	2002-09-06
CA2458776A1	Canada	A1	2003-03-06
WO03017981A1	World Intellectual Property Organization (WIPO)	A1	2003-03-06
EP1315478A2	European Patent Office (EPO)	A2	2003-06-04
US2003175341A1	United States of America	A1	2003-09-18
US6673369B2	United States of America	B2	2004-01-06
NO20041196L	Norway	L	2004-03-23
IN192748B	India	B	2004-05-15
EP1423097A1	European Patent Office (EPO)	A1	2004-06-02
EA200400343A1	Eurasian Patent Organization (EAPO)	A1	2004-08-26
BR0212259A	Brazil	A	2004-10-19
ZA200402007B	South Africa	B	2004-11-24
CN1575164A	China	A	2005-02-02
US2005053657A1	United States of America	A1	2005-03-10
PL368306A1This record	Poland	A1	2005-03-21
HUP0500791A2	Hungary	A2	2006-09-28

1 legal event, as the office reported them to INPADOC

Events

Legal events, newest first
	Event	Code
2009-10-30	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)REFS	REFS